Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation

Transplantation

Volumn 65, Issue 1, 1998, Pages 27-32

  Miyauchi, Takayuki ^a   Ishikawa, Masashi ^a   Tashiro, Seiki ^a   Hisaeda, Hajime ^a   Nagasawa, Hideyuki ^a   Himeno, Kunisuke ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ANIMALS; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; LYMPHOCYTE CULTURE TEST, MIXED; MALE; PERIOPERATIVE CARE; PORTAL VEIN; RATS; RATS, INBRED LEW; SPLEEN; TACROLIMUS;

EID: 0031886021     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199801150-00006     Document Type: Article

References (38)

1. Todo S, Tzakis AG, Abu-Elmagd K, et al. Intestinal transplantation in composite visceral grafts or alone. Ann Surg 1992; 216: 223.
2. Murase N, Demetris AJ, Matsuzaki T, et al. Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK506. Surg 1991; 110: 87.
3. Tzakis AG, Todo S, Reyes J, et al. Intestinal transplantation in children under FK506 immunosuppression. J Pediatr Surg 1993; 28: 1040.
4. Murase N, Demetris AJ, Woo J, et al. Graft-versus-host disease after Brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation 1993; 55: 1.
5. Green M, Reyes J, Nour B, Tzakis A, Todo S. Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. Transplant Proc 1994; 26: 1420.
6. Qian J-H, Hashimoto T, Fujiwara H, Hamaoka T. Studies on the induction of tolerance to alloantigens. I. The abrogation of delayed-type hypersensitivity responses to alloantigens by portal venous innoculation with allogenic cells. J Immunol 1985; 134: 3656.
7. Gorczynski RM. Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes. Immunol Lett 1992; 33: 67.
8. Rao VK, Burris DE, Gruel S, Sollinger NW, Burlingham WJ. Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in the rats. Transplantation 1988; 45: 1145.
9. Kobayashi E, Kamada N, Enosawa S, et al. Comparison of potentiability to induce graft-versus-host reaction with small bowel, pancreaus/spleen, and liver transplantation in the rat. Clin Exp Immunol 1993; 92: 527.
10. Zhang R, He G, Sakai Y, et al. The effect of donor-recipient strain combination on rejection and graft-versus-host disease after small bowel/liver transplantation in the rat. Transplantation 1993; 56: 381.
11. Saat RE, Heinemann E, de Bruin RWF, Marquet RL, Jeekel J. Total orthotopic allogenic small bowel transplantation in the rat: attempts to ameliorate the graft-versus-host disease by irradiation and transfusion of the donor. Transplantation 1989; 47: 451.
12. Rosemurgy AS, Schraut WH. Small bowel allografts: sequence of histologic changes in acute and chronic rejection. Am J Surg 1986; 151: 470.
13. Chase MW. Inhibition of experimental drug allergy by prior feeding of sensitizing agent. Proc Soc Exp Biol Med 1946; 61: 257.
14. Sulzberger NB, Arsphename hypersensitiveness in guinea-pig. II. Experiments demonstrating the role of skin, both as originator and as site of hypersensitiveness. Arch Dermatol Syphilol 1930; 22: 839.
15. Battisto JR, Miller J. Immunological unresponsiveness produced in adult guinea pigs by parenteral introduction of minute quantities of hapten or protein antigen. Proc Soc Exp Biol Med 1962; 111: 111.
16. Rubinstein D, Roska AJ, Lipsky PE. Liver sinusoidal linking cells express class II major histocompativility antigens but are poor stimulators of fresh allogenic T lymphocytes. J Immunol 1986; 137: 1803.
17. Triger DR, Cynamon MH, Wright R. Studies on hepatic uptake of antigen. I. Comparison of inferior vena cava and portal vein routes of immunization. Immunology 1973; 25: 951.
18. Fujiwara H, Qian J-H, Satoh S, et al. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type-hypersensitivitiy by portal venous inoculation with allogenic cells. J Immunol 1986; 136: 2763.
19. Gorczynski RM, Chen Z. Tolerance after portal venous immunization is enhanced by anti-IFN-γ and is maintained only with persistence of antigen. Transplant Proc 1995; 27: 227.
20. Kenik S, Lisbona R, Lowry RP, et al. Prolonged cardiac survival following portal venous inoculation of allogenic cells: immmunologically specific entrapment of allogenic cells within the liver. Transplant Proc 1987; 19: 3057.
21. Kamei T, Calley MP, Flye MW. Resident research award Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990; 48: 393.
22. Nakagawa K, Matsuno T, Haisa M, et al. Induction of MLR hyporesponsiveness after portal venous inoculation with donor splenocytes correlates with persistance of donor lymphocytes in host organs. Transplant Proc 1996; 28: 1295.
23. Kobayashi E, Kamada N, Enosawa S, Toyama N, Miyata M. Syngenic small-bowel grafting increases susceptibility to lethal graft-versus-host diseases in the rat. Eur Surg Res 1995; 27: 19.
24. Kimura K, Money SR, Jaffe BM. The effects of cyclosporine on varying segments of small-bowel grafts in the rat. Surgery 1988; 104: 64.
25. Kobayashi E, Toyama N, Kiyozaki H, et al. Small bowel transplantation for pediatric short bowel syndrome: evaluation of the graft length required for development and the immunologic aspects relating to graft length. J Pediatr Surg 1994; 29: 1331.
26. Markus PM, Cai X, Ming W, Demetris AJ, Fung JJ, Starzl TE. Prevention of graft-versus-host disease following allogenic bone marrow transplantation in rats using FK506. Transplantation 1991; 52: 590.
27. Dumont FJ, Staruch MJ, Koprak SK, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol 1990; 144: 1418.
28. Hoffmann AL, Makowka L, Banner B, et al. The use of FK-506 for small intestine allotransplantation. Transplantation 1990; 49: 483.
29. - T cells in the livers of mice innoculated with allogenic cells via the portal vein. Transplant Proc 1993; 25: 1022.
30. Chen Y, Inobe J, Marks R, Gonella P, Kochroo VK, Weiner HL. Periferal deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177.
31. Starzl TE, Demetris AJ. Transplantation milestones: viewed one- and two-way paradigms of tolerance. JAMA 1995; 273: 876.
32. Iwaki Y, Starzl TE, Yagihashi A, et al. Replacement of donor lymphoid tissue in human small bowel transplants under FK506 immunosuppression. Lancet 1991; 337: 818.
33. Murase N, Starzl TE, Tanabe M, Fujisaki S, et al. Variable chimerisms, grafting-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 1995; 60: 158.
34. Mosmann T, Cherwinski H, Bond MW, Giedlin MA, Coffmann RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348.
35. Nosal GJV. Immunologic tolerance: collaboration between antigen and lymphokine. Science 1989; 14: 1989.
36. Grant D, Zhang R, Gunn H, et al. Graft-versus-host disease associated with intestinal transplantation in the rat. Transplantation 1989; 48: 545.
37. Westra AL, Callery MP, Flye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat allograft survival. Surgery 1990; 108: 415.
38. Uda M, Fujiwara S, Matsuno T, Tanaka N, Orita K. Donor specific inhibitory factor induced by the portal venous inoculation with ultraviolet-B irradiated spleen cells in nonhuman primates. Transplant Proc 1994; 26: 1994.